Extendicare Inc. (TSE:EXE – Free Report) – Equities researchers at Leede Financial upped their FY2025 earnings per share estimates for Extendicare in a report released on Wednesday, November 13th. Leede Financial analyst D. Loe now forecasts that the company will post earnings of $1.29 per share for the year, up from their previous estimate of $0.90. The consensus estimate for Extendicare’s current full-year earnings is $0.61 per share. Leede Financial also issued estimates for Extendicare’s FY2026 earnings at $1.39 EPS.
Other equities research analysts have also recently issued reports about the stock. Royal Bank of Canada lifted their price objective on shares of Extendicare from C$8.50 to C$9.50 in a research note on Monday, August 19th. TD Securities increased their price objective on shares of Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a report on Thursday, November 14th.
Extendicare Stock Down 2.3 %
Shares of Extendicare stock opened at C$10.09 on Monday. The company has a debt-to-equity ratio of 305.80, a current ratio of 0.60 and a quick ratio of 0.98. Extendicare has a 1-year low of C$6.45 and a 1-year high of C$10.43. The business’s fifty day moving average price is C$9.30 and its two-hundred day moving average price is C$8.18. The company has a market capitalization of C$842.21 million, a P/E ratio of 14.84 and a beta of 1.26.
Extendicare Announces Dividend
The company also recently announced a monthly dividend, which was paid on Friday, November 15th. Investors of record on Thursday, October 31st were issued a dividend of $0.04 per share. This represents a $0.48 dividend on an annualized basis and a yield of 4.76%. The ex-dividend date was Thursday, October 31st. Extendicare’s payout ratio is currently 70.59%.
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
See Also
- Five stocks we like better than Extendicare
- What is a Death Cross in Stocks?
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- 3 Monster Growth Stocks to Buy Now
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.